Skip to main content
SpringerLink
Log in

Protective effects of thromboxane A2 synthetase inhibitor (OKY-046) on hepatic ischemia-reperfusion injury in rats with obstructive jaundice

  • Original Articles
  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

The effects of OKY-046, a thromboxane A2 synthetase inhibitor, on complete hepatic ischemia with obstructive jaundice were studied in male Wistar rats in vivo. The objective of this study was to investigate the influence of OKY-046 (i) on the hepatic microcirculation, as measured by tissue partial oxygen pressure (tPO2), and (ii) on the release of interleukin-8 (IL-8) in hepatic tissue after reperfusion. Fourteen days after bile duct clamping, the rats were subjected to 30-min warm complete liver ischemia and then reperfusion. The rats were divided into three groups; one group received no treatment (controls, group C), one group received OKY-046 from 15 min before hepatic ischemia to the end of the experiment (group OKY), and the third group received gadolinium chloride (group Gd), injected intravenously to evaluate the contribution of the Kupffer cell to IL-8 production. Group OKY maintained significantly higher tPO2 levels 5, 10, and 15 min after declamping compared to group C (P<0.05). The IL-8 level in liver tissue in group OKY was lower than that in group C, but the difference was not significant. Group Gd exhibited the lowest IL-8 level of the three groups (P < 0.05). These findings demonstrated that OKY-046 improved the hepatic microcirculation during the reperfusion period, influenced the Kupffer cells in terms of the avoidance of hypoxia, and depressed the concentration of IL-8 in liver tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Szczlik A, Gerglewski RJ, Musial L, Grodinska M, Serwonska L, Marcinkiewicz WS (1978) Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease. Acta Biol Med Der 37:741

    Google Scholar 

  2. Kuroe K, Kurokawa T, Nishikimi M, Nonami A, Harada A, Nakao A, Takagi H (1991) Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats. Eur Surg Res 23:20–26

    PubMed  Google Scholar 

  3. Suehiro T, Yanaga K, Itasaka H, Kishikawa K, Shirabe K, Sugimachi K (1994) Benificial effect of thromboxane A2 synthetase inhibitor on cold-stored rat liver. Transplantation 58:768–773

    PubMed  Google Scholar 

  4. Isozaki H, Okajima K, Hara H, Kobayashi M (1994) The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Jpn J Surg 24:435–440

    Google Scholar 

  5. Besse T, Gustin T, Claeys N, Schroeyers P, Lambotte L (1989) Effect of PGI2 and thromboxane antagonist on liver ischemic injury. Eur Surg Res 21:213–217

    PubMed  Google Scholar 

  6. Aronsen KF, Nylander G, Ohlson EG (1969) Liver blood flow studies during and after various periods of total biliary obstruction in the dog. Acta Chir Scand 135:55

    PubMed  Google Scholar 

  7. Iizuka K, Akahane K, Momose D, Nakazawa M (1981) Highly selective inhibitors of thromboxane synthetase. J Med Chem 24:1139–1148

    PubMed  Google Scholar 

  8. Kohbu Y, Arakawa K, Ikeda Koji, Shimada T, Ishikawa H, Kita K (1993) Development of oxygen electrode with temperature compensates (in Japanese with English abstract). Koube Daigaku Iryougijutsutankidaigakubu Kiyou 9:113–117

    Google Scholar 

  9. Iida M, Watanabe K, Tsurufuji M, Takaishi K, Iizuka Y, Tsurufuji S (1992) Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats. Infect Immun 60:1268–1272

    PubMed  Google Scholar 

  10. Nakagawa H, Ikesue A, Kato H, Debuchi H, Watanabe K, Tsurufuji S, Naganawa M, Mitamura M (1992) Changes in the levels of rat interleukin-8/CINC and gelatinase in the exudate of carrageenin-induced inflammation in rats. J Pharmacobiodyn 15:461–466

    PubMed  Google Scholar 

  11. Jaeschke H, Farhood A, Smith CW (1990) Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4:3355–3359

    PubMed  Google Scholar 

  12. Metinko A, Kunkel S, Standiford T, Strieter R (1991) Monocyte expression of interleukin-8 in response to oxidant stress (abstract). FASEB J 1:A704

    Google Scholar 

  13. Jaeschke H, Farhood A (1991) Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 260:G355-G362

    PubMed  Google Scholar 

  14. Kim YI, Kai T, Kitano S, Ishii T, Tatsuma T, Kamada N, Sugimachi K (1994) Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Transplantation 58:875–879

    PubMed  Google Scholar 

  15. Hanazaki K, Kuroda T, Haba Y, Shiohara E, Kajikawa S, Iida F (1994) Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. Surgery 116:896–903

    PubMed  Google Scholar 

  16. Helling T, Hacker K, Kragel P, Eisenstein C (1994) Evidence for cytoprotection by prostaglandin E1 with normothermic hepatic ischemia. J Surg Res 56:309–313

    PubMed  Google Scholar 

  17. Chavez-Cartaya R, Ramirez-Romero P, Calne R, Jamieson N (1994) Laster-Doppler flowmetry in the study of in vivo liver ischemia and reperfusion in the rat. J Surg Res 56:473–477

    PubMed  Google Scholar 

  18. Saito T (1993) The protective effect of prostaglandin I2 analog (OP-41483) on hemodynamics and oxygen metabolism in normothermic liver ischemia. Fukushima J Med Sci 39:43–62

    PubMed  Google Scholar 

  19. Chavez-Cartaya R, Metcalfe S, Ramirez-Romero P, Calne R, Jamieson N (1994) Rat liver blood flow after ischemia and reperfusion. Transplantation 57:1440–1444

    PubMed  Google Scholar 

  20. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD (1994) Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145: 1421–1431

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Surgery, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, 755, Yamaguchi, Japan

    Masahiko Orita

Authors
  1. Masahiko Orita
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Orita, M. Protective effects of thromboxane A2 synthetase inhibitor (OKY-046) on hepatic ischemia-reperfusion injury in rats with obstructive jaundice. J Hep Bil Pancr Surg 3, 60–65 (1996). https://doi.org/10.1007/BF01212782

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01212782

Key words

Search

Navigation